ReviewCureus2026
Fibrin Glue (Tisseel) in Pterygium Surgery: A Narrative Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pterygium is a common ocular surface disorder with a risk of recurrence following surgical excision. Conjunctival autografting is widely used to reduce recurrence, traditionally secured with sutures. Fibrin glue, including Tisseel (Baxter Healthcare Corporation, Deerfield, IL, USA), has been introduced as an alternative method of graft fixation. The objective of the study is to review the current evidence on the use of fibrin glue in pterygium surgery, with emphasis on surgical outcomes, recurrence rates, postoperative comfort, and complications. A narrative review of the literature was conducted using PubMed, Google Scholar, and the Cochrane Library. English-language studies evaluating fibrin glue for conjunctival autograft fixation in pterygium surgery were included. Across multiple studies, fibrin glue fixation was associated with shorter surgical duration and improved early postoperative comfort compared with sutured techniques. Recurrence rates were generally comparable between fibrin glue and sutures. Recent studies and meta-analyses have also demonstrated reduced conjunctival inflammation without an increase in significant complications. Fibrin glue represents a reliable alternative to sutures for conjunctival autograft fixation in pterygium surgery. Its use offers advantages in operative efficiency and patient comfort while maintaining acceptable recurrence and safety profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.